Balance Versus Bias: Correcting Misinformation About the 2025 American Thoracic Society Community-Acquired Pneumonia Guidelines

医学 误传 肺炎 重症监护医学 平衡(能力) 梅德林 2019年冠状病毒病(COVID-19) 2019-20冠状病毒爆发 医疗急救 风险评估
作者
Julio A. Ramirez,Barbara Ellen Jones,Eyal Oren,Nilam J. Soni,Marcos I. Restrepo,Daniel M. Musher,Brian L. Erstad,Chiagozie Ifeoma Pickens,Scott A. Helgeson,Kristina A. Crothers,Joshua P. Metlay,Britany Bissell,Bin Cao,James Duncan Chalmers,Charles S. Dela Cruz,Stephen Y. Liang,GRANT W. WATERER,Marilynn Paine,Conall J. Hawkins,Kevin C. Wilson
出处
期刊:Clinical Infectious Diseases [Oxford University Press]
卷期号:83 (1): e219-e220 被引量:1
标识
DOI:10.1093/cid/ciag153
摘要

To the Editor—We are deeply saddened that IDSA did not endorse the 2025 Clinical Practice Guidelines Update for Community-Acquired Pneumonia (CAP) [1, 2]. The update was approved by an equal number of clinical experts appointed by ATS and IDSA, along with 5 nonvoting methodologists and 2 patients after months of careful review of the evidence, discussion, and consensus. We are concerned that for future guideline collaborations with IDSA evaluating antibiotic use, achieving an “appropriate balance,” as suggested by Klompas et al may prove difficult if judgments about antibiotic use are driven primarily by stewardship perspectives. IDSA's statements that the recommendations are not evidence based and that they will increase antibiotic use are incorrect. Guideline panels and clinicians must make decisions for patients regardless of how many high-quality trials are available. The committee recognized a lack of high-quality evidence in the form of comparative trials. As a result, our recommendations are conditional (ie, not appropriate for a sizable minority of patients), and we emphasized the importance of individualization of care. In the absence of randomized controlled trials, the best available evidence may consist of observational studies, case series, and clinical experience; this is still considered evidence [3]. Previous guidelines recommend treating all people with pneumonia with antibiotics regardless of the result of viral tests, due to concerns about bacterial–viral coinfection [4]. While this risk cannot be ignored, we seriously considered the uncertainty of this risk due to imperfect diagnostic tools, lack of outcomes studies, and the heterogeneity and uncertainty in both the benefit and harm of antibiotics for different patients. As a result of this deliberation, the ATS guidelines are the first to suggest withholding antibiotics for a population of adults with CAP: those with mild disease and no comorbidities. This recommendation, along with approval of lung ultrasound to diagnose pneumonia and shorter duration of therapy for people with pneumonia reaching clinical stability, stands to dramatically reduce, not increase, the use of antibiotics and should be recognized as an advance for stewardship.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Pupupapa发布了新的文献求助10
刚刚
晚风发布了新的文献求助10
刚刚
刚刚
我爱我家完成签到 ,获得积分10
1秒前
haan发布了新的文献求助30
1秒前
2秒前
Stella发布了新的文献求助10
2秒前
晚荔酪发布了新的文献求助30
3秒前
zero完成签到 ,获得积分10
4秒前
4秒前
4秒前
柚子完成签到 ,获得积分10
4秒前
4秒前
4秒前
小一班www完成签到,获得积分10
5秒前
时尚白凡完成签到 ,获得积分10
5秒前
6秒前
6秒前
latata完成签到 ,获得积分10
6秒前
共享精神的应助被haan采纳,获得10
6秒前
兔飞发布了新的文献求助10
6秒前
晚风发布了新的文献求助10
7秒前
Li发布了新的文献求助10
7秒前
liu发布了新的文献求助200
8秒前
yyc完成签到,获得积分10
8秒前
8秒前
8秒前
Ava的应助被liuze采纳,获得10
9秒前
cwm发布了新的文献求助10
9秒前
坤子完成签到,获得积分10
10秒前
10秒前
chenzhaoyang发布了新的文献求助10
10秒前
香风智乃完成签到 ,获得积分10
10秒前
Ava的应助被大栗子采纳,获得10
10秒前
zhiguoxin完成签到,获得积分10
11秒前
chai完成签到,获得积分10
12秒前
blinkals57发布了新的文献求助10
12秒前
haan完成签到,获得积分10
13秒前
哈哈完成签到 ,获得积分10
13秒前
liu发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593